Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Folic acid dissolution

This article was originally published in The Tan Sheet

Executive Summary

All folic acid-containing vitamin products to be subject to dissolution requirements as of Nov. 15, the U.S. Pharmacopeia Subcommittee on Nonprescription Drugs and Nutritional Supplements voted at a meeting in Rockville, Md. April 14. Requirements would be expanded to all other folic acid products a year later. In the January-February issue of USP's Pharmacopeial Forum, the subcommittee proposed striking the provision requiring dissolution testing for folic acid products only if the labeling includes a health claim of the relationship between folate deficiency and neural tube defect risk ("The Tan Sheet" Feb. 2, p. 12). The Institute of Medicine Food & Nutrition Board recently recommended all women of childbearing age take 400 mcg of folic acid daily to reduce the risk of NTDs such as spina bifida ("The Tan Sheet" April 13, p. 16)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088345

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel